首页> 美国卫生研究院文献>Journal of Korean Medical Science >Correlation of mutation and immunohistochemistry of p53 in hepatocellular carcinomas in Korean people.
【2h】

Correlation of mutation and immunohistochemistry of p53 in hepatocellular carcinomas in Korean people.

机译:韩国人群肝细胞癌中p53突变与免疫组化的相关性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The degree of correlation between sequencing and immunohistochemisty (IHC) for detecting mutations of p53 has not been well established in human hepatocellular carcinoma (HCC). We analyzed 36 HCCs from Korean people for p53 mutation at exons 4-10 by PCR-SSCP and sequencing, and compared the results with the IHC positivity. p53 mutations were identified in 7 out of 36 HCCs (19.4%). These mutations were found widely throughout exons 4-8. No mutation was detected in codon 249. Among the 7 mutations, 6 missense mutations were detected in 15 HCCs with > or =5% immunoreactive tumor cells and one nonsense mutation was in 21 HCCs with <5% immunoreactive tumor cells. The sensitivity for p53 mutation was 85.7% (6/7), the specificity 69.0% (20/29), the predictive value of positive IHC 40.0% (6/15), and the predictive value of negative IHC 95.2% (20/21). Two missense mutations were detected in 25 cases with <10% immunoreactive tumor cells. Predictive values of both positive IHC and negative IHC were higher in > or =5% overexpression group than in > or =10% overexpression group or >0% overexpression group. This study suggests that 5% immunoreactivity is a reliable immunohistochemical threshold value to detect p53 mutations in HCCs and the spectrum of p53 mutations in HCCs in Korean people is different from that of high aflatoxin B1 exposure areas.
机译:在人类肝细胞癌(HCC)中,尚未确定用于检测p53突变的测序和免疫组化(IHC)之间的相关程度。我们通过PCR-SSCP和测序分析了韩国人的36例HCCs在第4-10号外显子的p53突变,并将结果与​​IHC阳性进行了比较。在36个HCC中有7个(19.4%)鉴定出p53突变。这些突变在第4-8外显子中广泛发现。在249位密码子中未检测到突变。在这7个突变中,在免疫反应性肿瘤细胞> 5%或= 5%的15个HCC中检测到6个错义突变,而免疫反应性肿瘤细胞<5%的21个HCC中检测到一个无意义的突变。 p53突变的敏感性为85.7%(6/7),特异性为69.0%(20/29),阳性IHC的预测值为40.0%(6/15),阴性IHC的预测值为95.2%(20/29) 21)。 25例免疫反应性<10%的肿瘤细胞中检测到两个错义突变。 >或= 5%过表达组中阳性IHC和阴性IHC的预测值均高于>或= 10%过表达组或> 0%过表达组。这项研究表明,5%的免疫反应性是检测肝癌中p53突变的可靠免疫组化阈值,而且韩国人中肝癌中p53突变的谱不同于高黄曲霉毒素B1暴露区域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号